110 related articles for article (PubMed ID: 3500441)
1. 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update.
Marini G; Simoncini E; Zaniboni A; Gorni F; Marpicati P; Zambruni A
Oncology; 1987; 44(6):336-40. PubMed ID: 3500441
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.
Marini G; Marpicati P; Zaniboni A; Cervi GC; Gorni F; Simoncini E
Chemioterapia; 1985 Apr; 4(2):135-8. PubMed ID: 3874000
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
6. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
Klaassen U; Harstrick A; Wilke H; Seeber S
Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
[TBL] [Abstract][Full Text] [Related]
9. Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.
Francini G; Petrioli R; Aquino A; Gonnelli S
Cancer Chemother Pharmacol; 1993; 32(5):359-64. PubMed ID: 7687933
[TBL] [Abstract][Full Text] [Related]
10. L-folinic acid and 5-fluorouracil in the treatment of advanced breast cancer: a phase II study.
Zaniboni A; Meriggi F; Arcangeli G; Marpicati P; Montini E; Simoncini E; Marini G
Ann Oncol; 1993; 4 Suppl 2():41-3. PubMed ID: 8353103
[TBL] [Abstract][Full Text] [Related]
11. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
[TBL] [Abstract][Full Text] [Related]
12. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil and high-dose folinic acid as second-line chemotherapy in head and neck cancer.
Merlano M; Bacigalupo A; Benasso M; Grimaldi A; Toma S; Benedetti G; Comella G; Cacace F; Rosso R
Am J Clin Oncol; 1990 Feb; 13(1):1-3. PubMed ID: 2305715
[TBL] [Abstract][Full Text] [Related]
15. Second-line treatment with high-dose 5-fluorouracil and folinic acid in advanced colorectal cancer refractory to standard-dose 5-fluorouracil treatment.
Jäger E; Klein O; Wächter B; Müller B; Braun U; Knuth A
Oncology; 1995; 52(6):470-3. PubMed ID: 7478433
[TBL] [Abstract][Full Text] [Related]
16. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
17. High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancer.
Barone C; Astone A; Garufi C; Grieco A; Cavallaro A; Netri G; Rossi S; Cassano A; Ricevuto E; Noviello MR
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1303-6. PubMed ID: 3500048
[TBL] [Abstract][Full Text] [Related]
18. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with 5-fluorouracil (5-FU) and high-dose folinic acid in solid tumors.
Marini G; Zaniboni A; Gorni F; Marpicati P; Montini E; Simoncini E
Drugs Exp Clin Res; 1987; 13(6):373-6. PubMed ID: 3498615
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 5-fluorouracil and high-dose folinic acid in advanced renal cell cancer.
Zaniboni A; Simoncini E; Marpicati P; Montini E; Ferrari V; Marini G
J Chemother; 1989 Oct; 1(5):350-1. PubMed ID: 2585035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
